Ronald E Bruehlman Iqvia Holdings Inc. (IQV) insider trading activity

Ronald E Bruehlman is Officer of IQVIA HOLDINGS INC.. Currently has a direct ownership of 35,476 shares of IQV, which is worth approximately $7.16 Million. The most recent transaction as insider was on Jan 28, 2025, when has been sold 2,201 shares (Common Stock) at a price of $203.43 per share, resulting in proceeds of $447,749. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.5K

13.01% 3M change

80.04% 12M change

Total Value Held $7.16 Million

Ronald E Bruehlman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 28 2025	SELL Payment of exercise price or tax liability	$447,749 $203.43 p/Share	2,201 Reduced 5.84%	35,476 Common Stock
Jan 28 2025	BUY Grant, award, or other acquisition	-	6,286 Added 14.3%	37,677 Common Stock
Feb 10 2024	SELL Payment of exercise price or tax liability	$197,907 $218.2 p/Share	907 Reduced 2.81%	31,391 Common Stock
Feb 09 2024	SELL Payment of exercise price or tax liability	$225,400 $218.2 p/Share	1,033 Reduced 3.1%	32,298 Common Stock
Feb 06 2024	SELL Payment of exercise price or tax liability	$2,264,820 $215.41 p/Share	10,514 Reduced 23.98%	33,331 Common Stock
Feb 06 2024	BUY Grant, award, or other acquisition	-	24,141 Added 35.51%	43,845 Common Stock
Aug 03 2023	SELL Payment of exercise price or tax liability	$559,758 $216.29 p/Share	2,588 Reduced 11.61%	19,704 Common Stock
Feb 10 2023	SELL Payment of exercise price or tax liability	$136,823 $222.84 p/Share	614 Reduced 2.68%	22,292 Common Stock
Feb 09 2023	SELL Payment of exercise price or tax liability	$165,132 $230.31 p/Share	717 Reduced 3.04%	22,906 Common Stock
Aug 03 2022	SELL Payment of exercise price or tax liability	$603,547 $233.21 p/Share	2,588 Reduced 9.87%	23,623 Common Stock
Feb 10 2022	BUY Grant, award, or other acquisition	-	5,869 Added 18.29%	26,224 Common Stock
Feb 09 2022	SELL Payment of exercise price or tax liability	$180,177 $255.57 p/Share	705 Reduced 3.35%	20,342 Common Stock
Oct 25 2021	SELL Open market or private sale	$1,028 $256.93 p/Share	4 Reduced 0.02%	26,224 Common Stock
Sep 23 2021	BUY Open market or private purchase	$1,051 $262.82 p/Share	4 Added 0.02%	26,228 Common Stock
Aug 03 2021	SELL Payment of exercise price or tax liability	-	2,391 Reduced 10.2%	21,047 Common Stock
Jul 20 2021	BUY Open market or private purchase	$3,189 $245.32 p/Share	13 Added 0.06%	20,355 Common Stock
Feb 09 2021	BUY Grant, award, or other acquisition	-	6,687 Added 22.2%	23,438 Common Stock

Also insider at

GDRX

GoodRx Holdings, Inc. Healthcare

Director

REB